Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in Asia
Status:
Completed
Trial end date:
2016-11-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of azilsartan medoxomil
(AZM) in Asian adult participants with both essential hypertension and type 2 diabetes.